MENU
Advertisement
View PDF Reprints
View Supplement
Pharmacologic Options for Treating Restenosis
By Osamu Iida, MD, and Yoshimitsu Soga, MD
left-arrow Created with Sketch. Previous Article
Comparing SFA Device Trials
By Michael R. Jaff, DO
Next Article right-arrow Created with Sketch.
The Restenosis Conundrum
How are reoccuring lesions in the SFA best treated and managed?
View Issue
Global Distribution Statement
Case Study: Acute Thrombus in the Proximal SFA Managed With the Liberant™ Thrombectomy System
By Rajesh K. Malik, MD
Case Study: Liberant™ Thrombectomy System to Remove Adherent Left Iliofemoral Vein Thrombus
By Ajit Rao, MD
Improving PAD Awareness, Access, and Amputation Prevention
With Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM
The 2026 AHA/ACC Guideline for the Management of Acute Pulmonary Embolism
By Geoffrey D. Barnes, MD, MSc; Allison Burnett, PharmD; Jay Giri, MD, MPH; and Soophia Naydenov, MD
Expanding Neurovascular Applications of the Swift™ Coil System
With Mohsen Nouri, MD; Robert M. Starke, MD; Allison E. Strickland, MD; and Nitin Goyal, MD
SEISMIQ™ IVL System as a Next-Generation Technology Offering for Complex PAD
With Jaafer Golzar, MD, FACC, FSCAI, and Gregory A. Stanley, MD, FACS
Three Keys to Creating and Maturing pAVFs for Successful Cannulation Safety
By Rishi Razdan, MD
